Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease…

By V. Athyros, K. Tziomalos, T. Gossios, T. Griva, P. Anagnostis, Konstantinos Kargiotis, E. Pagourelias, E. Theocharidou, A. Karagiannis, D. Mikhailidis. The Lancet, 2010

620 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/558c6451ed061347c234f57dbbe304ebaa797ec7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Z. Younossi
2. M. Rinella
3. K. Cusi
4. A. Sanyal
5. R. Loomba

In Epidemiology

1. Z. Younossi
2. M. Rinella
3. A. Sanyal
4. K. Cusi
5. E. Brunt
6. J. Lavine
7. N. Chalasani
8. S. Harrison

Citations in the corpus

• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018, background): “A recent posthoc analysis of the cardiovascular outcomes study, GREACE study The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study, observed that statins significantly improved aminotransferases and cardiovascular outcomes in patients with elevated aminotransferases presumed at”